Your browser doesn't support javascript.
loading
Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System.
Gordon, Noa; Goldstein, Daniel A; Tadmor, Boaz; Stemmer, Salomon M; Greenberg, Dan.
Afiliação
  • Gordon N; Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel.
  • Goldstein DA; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Tadmor B; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
  • Stemmer SM; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Greenberg D; Clalit Health Services, Tel-Aviv, Israel.
Front Pharmacol ; 12: 754390, 2021.
Article em En | MEDLINE | ID: mdl-34737706
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article